DNA Polymerase

Modification to extend the response date to September 12, 2018, 4:00 pm EST.
***************************************************************
This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Submit offers on NIAID-RFQ18-1921382.

This solicitation is a request for quotes (RFQ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-100, date August 22, 2018. The associated North American Industry Classification System (NAICS) code for this procurement is 325414 with a business size standard of 1250.

The National Institute of Allergy and Infectious Diseases (NIAID), in support of the Vaccine Research Center (VRC) is seeking New England BioLabs, Inc.'s Biologicals. Brand Name/Offeror must be a New England BioLabs, Inc authorized reseller by RFQ close. Please see attached Bill of Materials (BOM).

FOB Point shall be Destination: 40 Convent Drive, Bethesda, MD 20814

Period of Performance: 9/17/18 - 12/16/18

Vendor shall agree to the following: (1) Only order from the manufacturer at the time of the Governments necessity; (2) not to store the items in their warehouse; and (3) wait for the laboratory to request the specific item(s) and then take receipt of items from the manufacturer.

As a result of this RFQ, the government intends to award to the responsible contractor whose offer conforming to the solicitation will be most advantageous to the Government.

The firm fixed price award will be based on the following; price, capability to meet the requirements, delivery and the best value to the government.

The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (Aug 2018)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Aug 2018) Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items

The following contract clauses apply to this acquisition:
FAR 52.203-18, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
FAR 52.203-19, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
FAR 52.212-4 Contract Terms and Conditions Commercial Items (Aug 2018)
FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2018)
FAR 52.217-6 Option to Increase Quantity (Mar 1989)
FAR 52.222-43 Fair Labor Standards Act and Service Contract Labor Standards -- Price Adjustment (Multiple Year and Option Contracts) (Aug 2018)
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)
FAR 52.222-48 -Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment -- Certification. (May 2014)
HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
Quoter must include the following provision in their quote and check the appropriate response.
52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015)
(a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).
(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.
(c) Representation. By submission of its offer, the offeror represents that- (check one)
____(1) It is not an inverted domestic corporation: and
____(2) It is not a subsidiary of an inverted domestic corporation
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is an open-market combined synopsis/solicitation for New England BioLabs, Inc.'s Biologicals as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" (Quoter shall list exception(s) and rationale for the exception(s).)

Question and Answer session ends September 5, 2018, 1 p.m. Eastern

Submission shall be received not later than September 10, 2018, 8 a.m. Eastern

Offers may be e-mailed to akilah.bullock@nih.gov referencing NIAID-RFQ18-1921382. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

.